Drugs@FDA: FDA-Approved Drugs
Biologic License Application (BLA): 761143
Company: HORIZON THERAPEUTICS IRELAND
Company: HORIZON THERAPEUTICS IRELAND
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| TEPEZZA | TEPROTUMUMAB-TRBW | 500MG | INJECTABLE;INJECTION | Prescription | None | TBD | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 01/21/2020 | ORIG-1 | Approval | N/A; Orphan |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761143s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/761143Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/761143Orig1s000TOC.html |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 11/24/2025 | SUPPL-32 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761143s032lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761143Orig1s032ltr.pdf | |
| 08/26/2025 | SUPPL-31 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761143s031lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761143Orig1s031ltr.pdf | |
| 09/09/2025 | SUPPL-30 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761143s030lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761143Orig1s030ltr.pdf | |
| 04/13/2023 | SUPPL-24 | Supplement |
Label (PDF)
Letter (PDF) Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761143s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761143Orig1s024ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2024/761143Orig1s024MedR.pdf | |
| 07/17/2023 | SUPPL-23 | Supplement |
Label (PDF)
Letter (PDF) Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761143s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761143Orig1s023ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/761143Orig1s023.pdf | |
| 12/06/2022 | SUPPL-21 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761143s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761143Orig1s021ltr.pdf | |
| 10/26/2021 | SUPPL-14 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761143s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/761143Orig1s014ltr.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 11/24/2025 | SUPPL-32 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761143s032lbl.pdf | |
| 09/09/2025 | SUPPL-30 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761143s030lbl.pdf | |
| 08/26/2025 | SUPPL-31 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761143s031lbl.pdf | |
| 07/17/2023 | SUPPL-23 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761143s023lbl.pdf | |
| 04/13/2023 | SUPPL-24 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761143s024lbl.pdf | |
| 12/06/2022 | SUPPL-21 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761143s021lbl.pdf | |
| 10/26/2021 | SUPPL-14 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761143s014lbl.pdf | |
| 01/21/2020 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761143s000lbl.pdf |